TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ)
$4.33 0.01 (0.2315%)
Analysed TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) News Sources
Canaccord Lowers its Price Target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and Maintains a Buy Rating
12-03-2026
yahoo.com
VAREX IMAGING (VREX) Q2 Earnings and Revenues Miss Estimates
07-05-2026
yahoo.com
TriSalus (TLSI) Initiates Patient Enrollment for PREDICTT Liver Tumor Clinical Trial
10-05-2026
yahoo.com
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
12-05-2026
yahoo.com
TriSalus Life Sciences, Inc. Q1 2026 Earnings Call Summary
13-05-2026
moby.co
TriSalus Life Sciences Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...
13-05-2026
yahoo.com
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
10-06-2026
yahoo.com
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?
30-06-2026
yahoo.com
TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call
16-07-2026
yahoo.com
What is the current price of TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ)?
The current price of TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) is $4.33.
TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) since the previous trading day is $0.01.
TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) since the previous trading day is 0.2315%.
What is the most recent average sentiment score for TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ)?
The most recent average sentiment score for TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ)?
The most recent sentiment for TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ) is .
SEC-8K** Filing Available For TRISALUS LIFE SCIENCES INC (TLSI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.